Annual report pursuant to Section 13 and 15(d)

Note C - Shareholders' Equity - Options Exercisable (Details)

v3.10.0.1
Note C - Shareholders' Equity - Options Exercisable (Details) - $ / shares
12 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Exercisable (in shares) 30,500 38,950
Weighted average remaining contractual life (Year) 1 year 324 days 2 years 266 days
Weighted average exercise price (in dollars per share) $ 2.58 $ 2.79